Cargando…

Morphological Changes of Human Corneal Endothelial Cells after Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Administration: A Prospective Open-Label Clinical Study

PURPOSE: To investigate the effect and safety of a selective Rho kinase inhibitor, ripasudil 0.4% eye drops, on corneal endothelial cells of healthy subjects. DESIGN: Prospective, interventional case series. METHODS: In this study, 6 healthy subjects were administered ripasudil 0.4% in the right eye...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakagawa, Hiroko, Koizumi, Noriko, Okumura, Naoki, Suganami, Hideki, Kinoshita, Shigeru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569567/ https://www.ncbi.nlm.nih.gov/pubmed/26367375 http://dx.doi.org/10.1371/journal.pone.0136802

Ejemplares similares

Application of Rho Kinase Inhibitors for the Treatment of Corneal Endothelial Diseases
por: Okumura, Naoki, et al.
Publicado: (2017)

Crossover Randomized Study of Pharmacologic Effects of Ripasudil–Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine
por: Tanihara, Hidenobu, et al.
Publicado: (2023)

A selective inhibitor of the Rho kinase pathway, Y-27632, and its influence on wound healing in the corneal stroma
por: Yamamoto, Mayumi, et al.
Publicado: (2012)

A Close Look at the Clinical Efficacy of Rho-Associated Protein Kinase Inhibitor Eye Drops for Fuchs Endothelial Corneal Dystrophy
por: Kinoshita, Shigeru, et al.
Publicado: (2021)

Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction
por: Okumura, Naoki, et al.
Publicado: (2016)

Study protocol for a multicentre, open-label, single-arm phase I/II trial to evaluate the safety and efficacy of ripasudil 0.4% eye drops for retinopathy of prematurity
por: Arima, Mitsuru, et al.
Publicado: (2021)

Topical Ripasudil for the Treatment of Primary Corneal Endothelial Degeneration in Dogs
por: Michalak, Sarah R., et al.
Publicado: (2022)

Novel immunotherapeutic effects of topically administered ripasudil (K-115) on corneal allograft survival
por: Inomata, Takenori, et al.
Publicado: (2020)

Inhibition of TGF-β Signaling Enables Human Corneal Endothelial Cell Expansion In Vitro for Use in Regenerative Medicine
por: Okumura, Naoki, et al.
Publicado: (2013)

A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
por: Mizuno, Yu, et al.
Publicado: (2023)

Crosslinking-Induced Corneal Endothelium Dysfunction and Its Protection by Topical Ripasudil Treatment
por: Wang, Xuemei, et al.
Publicado: (2022)

Density-gradient centrifugation enables the purification of cultured corneal endothelial cells for cell therapy by eliminating senescent cells
por: Okumura, Naoki, et al.
Publicado: (2015)

Corneal Endothelial Expansion Promoted by Human Bone Marrow Mesenchymal Stem Cell-Derived Conditioned Medium
por: Nakahara, Makiko, et al.
Publicado: (2013)

Rho Kinase in Eye Disease
por: Okumura, Naoki, et al.
Publicado: (2017)

Perspective of Future Potent Therapies for Fuchs Endothelial Corneal Dystrophy
por: Okumura, Naoki, et al.
Publicado: (2018)

Cultivation of Corneal Endothelial Cells on a Pericellular Matrix Prepared from Human Decidua-Derived Mesenchymal Cells
por: Numata, Ryohei, et al.
Publicado: (2014)

Effect of the rho-kinase inhibitor ripasudil in needling with mitomycin C for the failure of filtering bleb after trabeculectomy: a cross-sectional study
por: Mizuno, Yu, et al.
Publicado: (2022)

Infliximab eye drops treatment in corneal neovascularization
por: Voiculescu, OB, et al.
Publicado: (2015)

Propranolol eye drops in patients with corneal neovascularization
por: Filippi, Luca, et al.
Publicado: (2018)

Effect of ripasudil on diabetic macular edema
por: Minami, Yoshiro, et al.
Publicado: (2019)

Ripasudil in a Model of Pigmentary Glaucoma
por: Wang, Chao, et al.
Publicado: (2020)

Corneal Penetration of Low-Dose Atropine Eye Drops
por: Austermann, Henning, et al.
Publicado: (2021)

Novel TACSTD2 mutation in gelatinous drop-like corneal dystrophy
por: Jongkhajornpong, Passara, et al.
Publicado: (2015)

Effectiveness of Ripasudil, a Rho-Associated Coiled/Coil-Containing Protein Kinase Inhibitor, in Improving Retinoschisis and Cystic-Like Foveal Cavities in Eyes with X-Linked Retinoschisis
por: Suimon, Hitomi, et al.
Publicado: (2020)

Rho-Associated Kinase Inhibitor Eye Drops in challenging cataract surgery
por: Antonini, Marco, et al.
Publicado: (2021)

Feasibility of cell-based therapy combined with descemetorhexis for treating Fuchs endothelial corneal dystrophy in rabbit model
por: Okumura, Naoki, et al.
Publicado: (2018)

Development of Poly Lactic/Glycolic Acid (PLGA) Microspheres for Controlled Release of Rho-Associated Kinase Inhibitor
por: Koda, Sho, et al.
Publicado: (2017)

Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
por: Sakamoto, Emi, et al.
Publicado: (2019)

Evaluation of cyclodextrins for enhancing corneal penetration of natamycin eye drops
por: Badhani, Anjali, et al.
Publicado: (2012)

The effect of loteprednol suspension eye drops after corneal transplantation
por: Chen, Yingxin, et al.
Publicado: (2021)

Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement
por: Fukushima, Atsuki, et al.
Publicado: (2014)

RNA-Seq–based transcriptome analysis of corneal endothelial cells derived from patients with Fuchs endothelial corneal dystrophy
por: Nakagawa, Tatsuya, et al.
Publicado: (2023)

Feasibility of a cryopreservation of cultured human corneal endothelial cells
por: Okumura, Naoki, et al.
Publicado: (2019)

Role of ripasudil as an adjunct treatment in the management of pseudoexfoliative glaucoma
por: Mohapatra, Sumita, et al.
Publicado: (2023)

Two novel mutations of TACSTD2 found in three Japanese gelatinous drop-like corneal dystrophy families with their aberrant subcellular localization
por: Nakatsukasa, Mina, et al.
Publicado: (2011)

Corneal sensitivity after topical bromfenac sodium eye-drop instillation
por: Yanai, Kaori, et al.
Publicado: (2013)

Undiluted Serum Eye Drops for the Treatment of Persistent Corneal Epitheilal Defects
por: Lekhanont, Kaevalin, et al.
Publicado: (2016)

A novel mutation in gelatinous drop-like corneal dystrophy and functional analysis
por: Nagahara, Yukiko, et al.
Publicado: (2019)

The ROCK Inhibitor Ripasudil Shows an Endothelial Protective Effect in Patients With Low Corneal Endothelial Cell Density After Cataract Surgery
por: Fujimoto, Hisataka, et al.
Publicado: (2021)

Fixed-Combination Eye Drops Based on Fluorometholone Nanoparticles and Bromfenac/Levofloxacin Solution Improve Drug Corneal Penetration
por: Otake, Hiroko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rh2agpobr8hppr6mspo6ngv2lj